Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
Clinical trial NCT06952842 · RECRUITING
Trial details
- NCT number
- NCT06952842
- Sponsor
- Chigenovo Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-04
- Primary completion
- 2030-06-18
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.